Clinical characteristics and plasma EBV-DNA levels
| Characteristics . | Patients . | |
|---|---|---|
| No. . | % . | |
| Age, y | ||
| Median (range) | 39 (15-71) | |
| Sex, male | 45 | 65.2 |
| Primary site | ||
| Nasal cavity | 58 | 84.1 |
| Others | 11 | 15.9 |
| B-symptoms | 26 | 37.7 |
| Elevated LDH level | 18 | 26.1 |
| Ann Arbor stage | ||
| I | 58 | 84.1 |
| II | 11 | 15.9 |
| ECOG | ||
| 0 | 39 | 43.5 |
| 1 | 30 | 56.5 |
| IPI | ||
| 0 | 46 | 66.7 |
| 1 | 19 | 27.5 |
| 2 | 4 | 5.8 |
| Pretreatment plasma EBV-DNA | ||
| Detectable | 58 | 84.1 |
| Median level, copies/mL (range) | 491 (0-453 125) | |
| Characteristics . | Patients . | |
|---|---|---|
| No. . | % . | |
| Age, y | ||
| Median (range) | 39 (15-71) | |
| Sex, male | 45 | 65.2 |
| Primary site | ||
| Nasal cavity | 58 | 84.1 |
| Others | 11 | 15.9 |
| B-symptoms | 26 | 37.7 |
| Elevated LDH level | 18 | 26.1 |
| Ann Arbor stage | ||
| I | 58 | 84.1 |
| II | 11 | 15.9 |
| ECOG | ||
| 0 | 39 | 43.5 |
| 1 | 30 | 56.5 |
| IPI | ||
| 0 | 46 | 66.7 |
| 1 | 19 | 27.5 |
| 2 | 4 | 5.8 |
| Pretreatment plasma EBV-DNA | ||
| Detectable | 58 | 84.1 |
| Median level, copies/mL (range) | 491 (0-453 125) | |